MetaCap

Bio Green Med Solution (BGMS) vs XTL Biopharmaceuticals (XTLB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bio Green Med Solution is the larger company by market cap ($3.7 million vs $3.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BGMS-34.94%XTLB-30.81%
+20%-9%-38%
Oct 7, 20261 yearNov 20, 2026
BGMS-34.86%XTLB-30.81%
+15%-11%-37%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BGMS versus XTLB key metrics
MetricBGMSXTLB
Share price$0.553$1.37
Market cap$3.66M$3.37M
1-day change-9.48%-5.84%
EPS (TTM)$-3.78$-0.36
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$0$451.00K
Revenue growth (YoY)-100.00%—
Net income (latest FY)$-3.00M$-1.03M
Gross margin—0.67%
Operating margin—-481.60%
Net margin—-227.72%
52-week high$2.80$5.64
52-week low$0.55$1.37
Distance from 52-week high-80.25%-75.71%
Average volume76.12K6.58K
Shares outstanding6.62M2.46M
Employees—4
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Bio Green Med Solution

BGMS stock →

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.

Health Care · Biotechnology: Pharmaceutical Preparations

About XTL Biopharmaceuticals

XTLB stock →

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

BGMS vs XTLB FAQ

Which is bigger, Bio Green Med Solution or XTL Biopharmaceuticals?

Bio Green Med Solution (BGMS) is larger, with a market capitalization of $3.66M compared with $3.37M for XTL Biopharmaceuticals (XTLB).

Are Bio Green Med Solution and XTL Biopharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons